These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20829621)

  • 41. Long-term cognitive effects of glucocorticoid excess in Cushing's syndrome.
    Forget H; Lacroix A; Bourdeau I; Cohen H
    Psychoneuroendocrinology; 2016 Mar; 65():26-33. PubMed ID: 26708069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic features.
    Dorn LD; Burgess ES; Dubbert B; Simpson SE; Friedman T; Kling M; Gold PW; Chrousos GP
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):433-42. PubMed ID: 7586617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cushing's syndrome.
    Schteingart DE
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):311-38. PubMed ID: 2663477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cushing's syndrome and hypertension.
    Danese RD; Aron DC
    Endocrinol Metab Clin North Am; 1994 Jun; 23(2):299-324. PubMed ID: 8070424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cushing's Syndrome and Steroid Dementia.
    Bernini G; Tricò D
    Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):50-55. PubMed ID: 27515536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erratum to "CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders" [Prog. Neuro-Psycol. Biol. Psychiatry, 26, 763 (2002)].
    Sonino N; Fava GA
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):1011-8. PubMed ID: 12369251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term negative impact on quality of life in patients with successfully treated Cushing's disease.
    Heald AH; Ghosh S; Bray S; Gibson C; Anderson SG; Buckler H; Fowler HL
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):458-65. PubMed ID: 15473878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and Management.
    Santos A; Resmini E; Pascual JC; Crespo I; Webb SM
    Drugs; 2017 May; 77(8):829-842. PubMed ID: 28393326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological management of Cushing's syndrome: an update.
    Dang CN; Trainer P
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1339-48. PubMed ID: 18209872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical management of Cushing's syndrome.
    Vance ML
    Endocr Pract; 2013; 19(2):193. PubMed ID: 23598532
    [No Abstract]   [Full Text] [Related]  

  • 51. Diagnosis of cure in Cushing's syndrome: lessons from long-term follow-up.
    Barahona MJ; Resmini E; Sucunza N; Webb SM
    Front Horm Res; 2010; 38():152-157. PubMed ID: 20616506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Residual symptoms in depression an emerging therapeutic concept.
    Sonino N; Fava GA
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):763-70. PubMed ID: 12188108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cushing's syndrome in a manic patient with a long-standing bipolar disorder: cause or coincidence?].
    de Witte LD; Smits RB; Bartel M; Kleijweg M; Valk GD; Vinkers CH; Vergeer M
    Tijdschr Psychiatr; 2015; 57(10):757-61. PubMed ID: 26479256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The medical management of Cushing's syndrome.
    Morris D; Grossman A
    Ann N Y Acad Sci; 2002 Sep; 970():119-33. PubMed ID: 12381547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drugs in the medical treatment of Cushing's syndrome--an update on mifepristone and pasireotide.
    Schteingart DE
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):279-83. PubMed ID: 22533823
    [No Abstract]   [Full Text] [Related]  

  • 56. Psychological complications of Cushing's syndrome.
    Santos A; Webb SM; Resmini E
    Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):325-329. PubMed ID: 33764929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mifepristone: is there a place in the treatment of Cushing's disease?
    Carmichael JD; Fleseriu M
    Endocrine; 2013 Aug; 44(1):20-32. PubMed ID: 23192246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality of life in Cushing's syndrome.
    Bride MM; Crespo I; Webb SM; Valassi E
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101505. PubMed ID: 33707083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Manic-depressive symptom associated with endocrine and metabolic disorders].
    Yamada T
    Nihon Rinsho; 1994 May; 52(5):1311-7. PubMed ID: 8007407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropsychiatric disorders and cognitive dysfunction in patients with Cushing's disease.
    Chen YF; Li YF; Chen X; Sun QF
    Chin Med J (Engl); 2013 Aug; 126(16):3156-60. PubMed ID: 23981629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.